Fluorodeoxyglucose-18
ID: W81K0224Q0103Type: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M MRCO PACIFICFORT SHAFTER, HI, 96858-5098, USA

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/f8031bd3595b433296a7fcbdfdf870b2/view
Timeline
    Description

    The Department of Defense, specifically the Department of the Army, is planning to award a sole source contract for Fluorodeoxyglucose-18 (FDG-18) to Hamamatsu-Queen's PET Imaging Center for use at Tripler Army Medical Center in Hawaii. This procurement, which falls under the NAICS code 325412, is intended to support medical readiness and will span from October 1, 2024, through September 30, 2029, including four one-year option periods. FDG-18 is a critical radiopharmaceutical used in positron emission tomography (PET) imaging, essential for various diagnostic procedures. Interested parties may submit capability statements or quotations for consideration, and all inquiries should be directed to Wendi Young-Asao at wendi.t.young-asao.civ@health.mil.

    Point(s) of Contact
    Wendi Young-Asao
    wendi.t.young-asao.civ@health.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Fluorodeoxyglucose-18
    Currently viewing
    Presolicitation
    Fluorodeoxyglucose 18 (18F-FDG)
    Sources Sought
    Similar Opportunities
    6505--Pylarify(Piflufolastat F18 Injection) for DC VAMC
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified sources to provide Pylarify (Piflufolastat F18 Injection) for the DC Veterans Affairs Medical Center (DC VAMC) in Washington, D.C. The procurement involves the delivery of this radiopharmaceutical to the Nuclear Medicine Section of the Radiology Service, with a base contract period of one year and four optional one-year extensions. This product is critical for diagnostic imaging and treatment in nuclear medicine, and the contractor must ensure compliance with various regulatory standards while providing online ordering capabilities and timely deliveries. Interested parties should submit their responses, including company information and capabilities, to Ryan Singletary at Ryan.Singletary@va.gov by September 16, 2024, at 3:00 PM EST.
    Piflufolastat F-18 injection drugs (Pylarify) from Sofie Co. (Notice of Intent to sole source)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole-source contract with Sofie Co. for the procurement of Piflufolastat F-18 injection drugs (Pylarify) essential for clinical nuclear medicine procedures at the NIH Clinical Center. This acquisition aims to secure compounded, patient-ready doses of the radiopharmaceutical, which is critical for diagnosing and treating diseases in accordance with patient care protocols. The drugs are FDA-approved and must be compounded and delivered on a time-sensitive basis due to their rapid radiation decay, making Sofie Co. the only authorized provider capable of meeting these specialized requirements. Interested parties may submit capability statements by September 18, 2024, to Lu Chang at lu-chang.lu@nih.gov, as this is not a request for proposals.
    6505--Supply, Axumin-Axumin + Cerianna Medicines - Nuclear Med, CLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to solicit and negotiate exclusively with PetNet Solutions and TrillaMed for the supply of three proprietary radiopharmaceuticals—Axumin, Amyvid, and Cerianna—for the Nuclear Medicine Service at the Louis Stokes Cleveland VA Medical Center. These products are critical for diagnosing recurrent prostate cancer, breast cancer, and Alzheimer’s disease, necessitating the use of a local radiopharmacy due to their radioactive nature and short shelf life. Interested vendors may submit their capabilities until September 18, 2024, to determine if a competitive procurement process is feasible, with all inquiries directed to Contract Specialist Don Caldwell at don.caldwell@va.gov.
    Pharmaceutical Preparation Manufacturing
    Active
    Dept Of Defense
    Sources Sought DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking local sources capable and interested in fulfilling a requirement for the procurement and delivery of CLASS VIII, Medical Laboratory Reagents, in support of United States Naval Hospital (USNH), located in Okinawa, Japan. The procurement is for ULTRA TECHNE KOW 18.5GBq Injection Generator, with an estimated quantity of 26 units per year. The delivery location will be the United States Naval Hospital (USNH) Okinawa Nuclear Medicine Department, Camp Foster, Okinawa, Japan. Interested parties should provide company information, capability to provide the items, and item lead times. Responses must be submitted by Thursday, November 09, 2023, via email to jasielle.castro@dla.mil and mamiko.jackson@dla.mil.
    American College of Radiology
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to make a Sole Source Award to the American College of Radiology (ACR) for the accreditation of multiple mammography units. This procurement involves the first unit fees for Mammography Units 11, 12, 13, and 14, each requiring two modules for accreditation. The services are critical for ensuring compliance with health standards and maintaining the quality of radiological services provided to military personnel. Interested parties can reach out to Luis Zeno at luis.a.zeno-pimentel.civ@health.mil or call 757-953-6084 for further details, as the award will be made following the close of the posting period.
    Reference Laboratory Testing Services
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to award a sole source contract for Reference Laboratory Testing Services to Diagnostic Laboratory Services, Inc. This contract will support the Laboratory Department at Naval Hospital Guam by providing comprehensive diagnostic testing and specialized laboratory services, including blood tests, genetic testing, and microbiology, which are critical for ensuring timely and accurate patient diagnoses. The contract is set to begin on September 19, 2024, with options for extension through September 30, 2026, and interested vendors must submit capability statements by 1:00 PM Pacific Daylight Time on September 12, 2024, to Merlinda Labaco at merlinda.m.labaco.civ@health.mil for consideration.
    Maintenance for fMRI software
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract to Nordic Neuro Lab, Inc. for maintenance services related to the existing NordicBrain software and hardware at Walter Reed National Military Medical Center (WRNMMC) in Bethesda, Maryland. This procurement aims to ensure ongoing support and maintenance of specialized medical software and hardware that are critical for the operations of the Radiology Department at WRNMMC. The contract will be awarded under the authority permitting Other than Full and Open Competition, with interested parties required to express their capabilities by 10:00 AM EST on September 19, 2024, via email to the primary contact, Ealed Nuru, at ealed.m.nuru.civ@health.mil, with a copy to Erica S. Oh at erica.s.oh.civ@health.mil.
    Procurement of Florescence Nuclear Track Detector (FNTD) items
    Active
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army, is seeking procurement for three Florescence Nuclear Track Detector (FNTD) items to enhance radiation detection capabilities. The required equipment includes one FNTD Automatic Reader, one FNTD Optical Character Recognition unit, and one RadWatch Optically Stimulated Luminescence Annealer, which are critical for improving testing and diagnostic capabilities in military operations. This procurement is part of a strategic investment aimed at bolstering national defense infrastructure through advanced radiation detection technologies. Interested vendors should direct inquiries to Taylor Siskoff at taylor.c.siskoff.civ@army.mil or Portia Sampson at portia.r.sampson.civ@army.mil, with delivery expected at the USATA facility in Redstone Arsenal, Alabama.
    Medical Lab Technician and Medical Lab Technologists
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking to negotiate a sole-source contract with Distinctive Health Spectrum Care JV LLC for the provision of medical laboratory personnel at the Naval Hospital Guam. The procurement aims to add two Medical Lab Technologists and one Medical Lab Technician under contract HT001418D0029, Task Order N6264521F0140, for the period from October 1, 2024, to June 27, 2025, reflecting the critical need for laboratory testing services in a military healthcare setting. Interested parties may submit capability statements for consideration, although the government may opt not to pursue competitive proposals based on the responses received, with a deadline for challenges set for September 26, 2024. For further inquiries, interested vendors can contact Uyen Tran at uyen.t.tran6.civ@health.mil.
    Avalon FM50 Fetal Heart Monitor
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking qualified vendors to provide the Philips Avalon FM50 Fetal Heart Monitor and associated equipment for the United States Naval Hospital in Guam. This procurement is essential for enhancing maternal and fetal care, particularly for high-risk pregnancies, as the monitor offers unique features such as simultaneous monitoring of multiple fetuses and advanced diagnostic capabilities. Interested vendors must comply with federal regulations, including registration in the System for Award Management (SAM), and submit their quotes electronically by noon on September 23, 2024, detailing their technical capabilities and pricing. For further inquiries, vendors can contact Merlinda Labaco at merlinda.m.labaco.civ@health.mil or Renier Valdez at renier.s.valdez.civ@health.mil.